Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 72,788 | 64,864 | 68,481 | 45,871 | 37,958 |
| Cost of Goods | 3,208 | 2,633 | 2,706 | 2,100 | 1,279 |
| Gross Profit | 69,580 | 62,231 | 65,775 | 43,771 | 36,679 |
| Operating Expenses | 109,783 | 97,066 | 129,029 | 101,297 | 106,311 |
| Operating Income | -39,995 | -34,202 | -62,548 | -57,426 | -69,353 |
| Interest Expense | 12,676 | 11,846 | 10,870 | 8,283 | 7,858 |
| Other Income | 3,308 | 3,375 | 5,404 | 4,994 | 5,364 |
| Pre-tax Income | -49,363 | -42,673 | -68,014 | -60,715 | -71,847 |
| Net Income Continuous | -49,363 | -42,673 | -68,014 | -60,715 | -71,847 |
| Net Income | $-49,363 | $-42,673 | $-68,014 | $-60,715 | $-71,847 |
| EPS Basic Total Ops | -0.55 | -0.48 | -0.78 | -0.70 | -0.83 |
| EPS Basic Continuous Ops | -0.55 | -0.48 | -0.78 | -0.70 | -0.83 |
| EPS Diluted Total Ops | -0.55 | -0.48 | -0.78 | -0.70 | -0.83 |
| EPS Diluted Continuous Ops | -0.55 | -0.48 | -0.78 | -0.70 | -0.83 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.48 | -0.78 | -0.70 | -0.83 |
| EBITDA(a) | $-40,523 | $-34,874 | $-64,076 | $-59,774 | $-72,730 |